Peng Zhang

Northwestern University — United States

Immunology and Microbiology · Life Sciences

15h-index1.3kcitations39works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(14), Immune cells in cancer(14), Cancer Immunotherapy and Biomarkers(12), CAR-T cell therapy research(8), Glioma Diagnosis and Treatment(5)

Publications39 total

DDDR-26. Preclinical evaluation of first-in-class PROTAC survivin degrader HMAK101 for radiosensitization of CNS malignancies
Neuro-Oncology·2025Open Access
TMIC-72. Glioma-associated myeloid cells promote B cell inhibition
Neuro-Oncology·2025Open Access
Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization
Nature Communications·2025· 6 citedOpen Access
Dual aVß8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Tumor Immunity
Neuro-Oncology·2025· 5 citedOpen Access
Microglial Fructose Metabolism Is Essential for Glioblastoma Growth
2025Open Access
A covalent creatine kinase inhibitor ablates glioblastoma migration and sensitizes tumors to oxidative stress
Scientific Reports·2024· 8 citedOpen Access
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
Neuro-Oncology·2024· 8 citedOpen Access
Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation
Cells·2024· 8 citedOpen Access
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Frontiers in Immunology·2024· 17 citedOpen Access
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma
Frontiers in Immunology·2024· 8 citedOpen Access
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Cell Metabolism·2023· 48 citedOpen Access
EXTH-24. FC-ENHANCED ANTI-CTLA-4 IMMUNE CHECKPOINT BLOCKADE AND ITS COMBINATION WITH ANTI-PD-1 WITH CONCOMITANT DOXORUBICIN AND ULTRASOUND-MEDIATED BBB OPENING: A NOVEL IMMUNOTHERAPY FOR GLIOBLASTOMA
Neuro-Oncology·2023Open Access
IMMU-31. B-CELL THERAPY (BVAX) PROMOTES CD8 T CELLS' PERSISTENCE AND FUNCTION IN THE GLIOBLASTOMA MICROENVIRONMENT BY MAINTAINING THEIR STEM-LIKE FEATURES
Neuro-Oncology·2023Open Access
GLUT3 regulates alternative macrophage signaling through a glucose transport–independent role
Journal of Clinical Investigation·2023· 12 citedOpen Access
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases
Journal of Clinical Investigation·2023· 17 citedOpen Access
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Nature Communications·2023· 195 citedOpen Access
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
Nature Communications·2023· 39 citedOpen Access
Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment
Molecular Cancer Research·2023· 7 citedOpen Access
B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated Immunosuppression
2023· 4 citedOpen Access
Abstract B36: Nano-engineering of immunosuppressive myeloid cells for immunostimulation in glioblastoma
Cancer Immunology Research·2022
page 1 of 2Next →

Frequent Co-authors

Jason Miska(35), Maciej S. Lesniak(29), Catalina Lee-Chang(24), Aida Rashidi(21), Aurora Lopez‐Rosas(21), Yu Han(19), David Hou(17), Brandyn Castro(15), Ting Xiao(13), Adam M. Sonabend(13), Víctor A. Arrieta(12), Crismita Dmello(11), Tzu-Yi Chia(10), Atique U. Ahmed(9), Irina V. Balyasnikova(9), Amy B. Heimberger(9), Junfei Zhao(8), Craig Horbinski(8), Roger Stupp(8), Joshua L. Katz(8)